Kurzawski M[au] - Search Results

Year	Number of Results
2003	1
2004	1
2005	8
2006	11
2007	12
2008	7
2009	11
2010	10
2011	11
2012	17
2013	10
2014	11
2015	12
2016	10
2017	6
2018	7
2019	4
2020	6
2021	6
2022	1

1

Pharmacogenetic considerations in the treatment of Parkinson's disease.

Kurzawski M, Białecka M, Droździk M. Kurzawski M, et al. Neurodegener Dis Manag. 2015;5(1):27-35. doi: 10.2217/nmt.14.38. Neurodegener Dis Manag. 2015. PMID: 25711452 Review.

2

Synthesis and Anticancer Activity of Mitotic-Specific 3,4-Dihydropyridine-2(1H)-thiones.

Perużyńska M, Borzyszkowska-Ledwig A, Sośnicki JG, Struk Ł, Idzik TJ, Maciejewska G, Skalski Ł, Piotrowska K, Łukasik P, Droździk M, Kurzawski M. Perużyńska M, et al. Among authors: kurzawski m. Int J Mol Sci. 2021 Feb 28;22(5):2462. doi: 10.3390/ijms22052462. Int J Mol Sci. 2021. PMID: 33671106 Free PMC article.

3

Monocarboxylate Transporter 1 (MCT1) in Liver Pathology.

Droździk M, Szeląg-Pieniek S, Grzegółkowska J, Łapczuk-Romańska J, Post M, Domagała P, Miętkiewski J, Oswald S, Kurzawski M. Droździk M, et al. Among authors: kurzawski m. Int J Mol Sci. 2020 Feb 26;21(5):1606. doi: 10.3390/ijms21051606. Int J Mol Sci. 2020. PMID: 32111097 Free PMC article.

4

[The role of microRNAs in the pathogenesis and progression of liver diseases].

Szeląg S, Kurzawski M. Szeląg S, et al. Among authors: kurzawski m. Pomeranian J Life Sci. 2016;62(3):5-15. Pomeranian J Life Sci. 2016. PMID: 29537241 Review. Polish.

5

Pharmacogenetics in solid organ transplantation: genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs.

Kurzawski M, Droździk M. Kurzawski M, et al. Pharmacogenomics. 2013 Jul;14(9):1099-118. doi: 10.2217/pgs.13.89. Pharmacogenomics. 2013. PMID: 23837483 Review.

6

Gene Expression and Protein Abundance of Hepatic Drug Metabolizing Enzymes in Liver Pathology.

Drozdzik M, Lapczuk-Romanska J, Wenzel C, Szelag-Pieniek S, Post M, Skalski Ł, Kurzawski M, Oswald S. Drozdzik M, et al. Among authors: kurzawski m. Pharmaceutics. 2021 Aug 25;13(9):1334. doi: 10.3390/pharmaceutics13091334. Pharmaceutics. 2021. PMID: 34575411 Free PMC article.

7

Hepatic drug-metabolizing enzymes and drug transporters in Wilson's disease patients with liver failure.

Szeląg-Pieniek S, Oswald S, Post M, Łapczuk-Romańska J, Droździk M, Kurzawski M. Szeląg-Pieniek S, et al. Among authors: kurzawski m. Pharmacol Rep. 2021 Oct;73(5):1427-1438. doi: 10.1007/s43440-021-00290-8. Epub 2021 Jun 11. Pharmacol Rep. 2021. PMID: 34117631 Free PMC article.

8

[Pharmacogenetics in Parkinson's disease treatment].

Białecka M, Kłodowska-Duda G, Kurzawski M, Droździk M. Białecka M, et al. Among authors: kurzawski m. Neurol Neurochir Pol. 2008 Mar-Apr;42(2):131-8. Neurol Neurochir Pol. 2008. PMID: 18512170 Review. Polish.

9

The reference liver-CYP450 and UGT enzymes in healthy donor and metastatic livers: the impact of genotype.

Kurzawski M, Szeląg-Pieniek S, Łapczuk-Romańska J, Wrzesiński M, Oswald S, Droździk M. Kurzawski M, et al. Pharmacol Rep. 2022 Feb;74(1):204-215. doi: 10.1007/s43440-021-00337-w. Epub 2021 Nov 6. Pharmacol Rep. 2022. PMID: 34741761

10

Association of COMT gene variability with pain intensity in patients after total hip replacement.

Machoy-Mokrzyńska A, Starzyńska-Sadura Z, Dziedziejko V, Safranow K, Kurzawski M, Leźnicka K, Sulżyc-Bielicka V, Jurewicz A, Bohatyrewicz A, Białecka M. Machoy-Mokrzyńska A, et al. Among authors: kurzawski m. Scand J Clin Lab Invest. 2019 May;79(3):202-207. doi: 10.1080/00365513.2019.1576920. Epub 2019 Mar 1. Scand J Clin Lab Invest. 2019. PMID: 30822160

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results